Metabolic basis for the differential susceptibility of Gram-positive pathogens to fatty acid synthesis inhibitors
Open Access
- 29 August 2011
- journal article
- Published by Proceedings of the National Academy of Sciences in Proceedings of the National Academy of Sciences of the United States of America
- Vol. 108 (37), 15378-15383
- https://doi.org/10.1073/pnas.1109208108
Abstract
The rationale for the pursuit of bacterial type 2 fatty acid synthesis (FASII) as a target for antibacterial drug discovery in Gram-positive organisms is being debated vigorously based on their ability to incorporate extracellular fatty acids. The regulation of FASII by extracellular fatty acids was examined in Staphylococcus aureus and Streptococcus pneumoniae, representing two important groups of pathogens. Both bacteria use the same enzymatic tool kit for the conversion of extracellular fatty acids to acyl-acyl carrier protein, elongation, and incorporation into phospholipids. Exogenous fatty acids completely replace the endogenous fatty acids in S. pneumoniae but support only 50% of phospholipid synthesis in S. aureus. Fatty acids overcame FASII inhibition in S. pneumoniae but not in S. aureus. Extracellular fatty acids strongly suppress malonyl-CoA levels in S. pneumoniae but not in S. aureus, showing a feedback regulatory system in S. pneumoniae that is absent in S. aureus. Fatty acids overcame either a biochemical or a genetic block at acetyl-CoA carboxylase (ACC) in S. aureus, confirming that regulation at the ACC step is the key difference between these two species. Bacteria that possess a stringent biochemical feedback inhibition of ACC and malonyl-CoA formation triggered by environmental fatty acids are able to circumvent FASII inhibition. However, if exogenous fatty acids do not suppress malonyl-CoA formation, FASII inhibitors remain effective in the presence of fatty acid supplements.Keywords
This publication has 45 references indexed in Scilit:
- Expression of Vibrio harveyi Acyl-ACP Synthetase Allows Efficient Entry of Exogenous Fatty Acids into the Escherichia coli Fatty Acid and Lipid A Synthetic PathwaysBiochemistry, 2009
- Waves of resistance: Staphylococcus aureus in the antibiotic eraNature Reviews Microbiology, 2009
- AFN-1252, a FabI Inhibitor, Demonstrates a Staphylococcus-Specific Spectrum of ActivityAntimicrobial Agents and Chemotherapy, 2009
- Acyl-Acyl Carrier Protein Regulates Transcription of Fatty Acid Biosynthetic Genes via the FabT Repressor in Streptococcus pneumoniaeOnline Journal of Public Health Informatics, 2009
- A class of selective antibacterials derived from a protein kinase inhibitor pharmacophoreProceedings of the National Academy of Sciences of the United States of America, 2009
- Andrimid producers encode an acetyl-CoA carboxyltransferase subunit resistant to the action of the antibioticProceedings of the National Academy of Sciences of the United States of America, 2008
- Lipid A Modification Systems in Gram-Negative BacteriaAnnual Review of Biochemistry, 2007
- Discovery of platencin, a dual FabF and FabH inhibitor with in vivo antibiotic propertiesProceedings of the National Academy of Sciences of the United States of America, 2007
- Structural basis of lipid biosynthesis regulation in Gram-positive bacteriaThe EMBO Journal, 2006
- Novel Bacterial Acetyl Coenzyme A Carboxylase Inhibitors with Antibiotic Efficacy In VivoAntimicrobial Agents and Chemotherapy, 2006